Evonik Showcases Cutting-Edge Biotechnology and Local Innovations at PCHi 2025 in Guangzhou

Evonik Showcases Cutting-Edge Biotechnology and Local Innovations at PCHi 2025 in Guangzhou

(IN BRIEF) Evonik will present its expanded portfolio at PCHi 2025 in Guangzhou, showcasing advanced biotechnology and products tailored to the regional market across various sectors. The company’s Care Solutions business focuses on meeting the growing demand for eco-friendly and scientifically validated products in China, offering system solutions that integrate products, technologies, and services. Key innovations include HAIRMIMICS® Boost for hair care, SPHINGONY® sphingolipid for skin and scalp, Golden C® NG for advanced Vitamin C delivery, and sustainable biosurfactants. Evonik also introduces dermosoft® EcoLact C MB for dandruff and symbio®pure G3C2 MB for makeup removers, addressing local market needs and consumer preferences.

(PRESS RELEASE) ESSEN, 13-Feb-2025 — /EuropaWire/ — Evonik will showcase its expanded portfolio at PCHi 2025 in Guangzhou from February 19-21, highlighting its advanced biotechnology and products designed specifically for the regional market. The company will feature innovations in sectors including active ingredients, skin care, sun care, hair care, cleansing, product protection, as well as household cleaning and air care applications.

Evonik’s Care Solutions business is committed to being a preferred partner in the beauty, personal care, and cleaning markets, offering comprehensive system solutions to meet the growing demand for eco-friendly, scientifically validated products in China. These system solutions are multi-component offerings across products, technologies, and services, tailored to unique customer needs and demonstrating proven sustainability benefits.

Alix Chen, general manager of Evonik’s Care Solutions business line in Greater China, stated, “We are excited to introduce more biotechnology-powered innovations that bring substantial performance improvements and sustainable benefits. With a locally focused organizational structure, we are now able to respond to market demands more swiftly and accurately.”

At PCHi 2025, Evonik will highlight several key innovations, including:

  • Leadership in Ceramide Innovation: HAIRMIMICS® Boost is a ceramide solution that supports healthy, resilient hair by providing essential lipids. SPHINGONY® sphingolipid is a powerful active ingredient offering multifunctional benefits for skin, hair, and scalp, reducing greasy hair, lengthening eyelashes, and boosting ceramide production.
  • Advanced Delivery Systems: Evonik leads in advanced delivery technologies, offering encapsulated solutions that significantly enhance cosmetic product performance. Golden C® NG, a gold-stabilized ascorbic acid, offers premium Vitamin C with unmatched stability and bioavailability in aqueous formulations, enabling formulators to develop innovative products.
  • Sustainable Biosurfactants: Following the opening of the world’s first industrial-scale rhamnolipid biosurfactant production facility in Slovakia, Evonik is advancing sustainable solutions across industries. Its biosurfactant platform includes RHEANCE® One and SOPHANCE® LA-A for personal care, and REWOFERM® series for household cleaning, all derived from renewable corn feedstocks and fully biodegradable.
  • Tailored Local Care Solutions: Evonik introduces dermosoft® EcoLact C MB, an anti-dandruff agent specially formulated for the Chinese market. Additionally, the company unveils symbio®pure G3C2 MB, a solubilizer developed for natural, sensitive-skin-friendly makeup removers, offering a gentle yet effective cleansing solution.

To learn more, visit Evonik’s booth 3K28 in Hall 3.1 at the China Import and Export Fair Complex in Guangzhou from February 19-21, or follow the Evonik Personal Care WeChat account.

About Evonik

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15.3 billion and an operating profit (adjusted EBITDA) of €1.66 billion in 2023. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 32,000 employees work together for a common purpose: We want to improve life today and tomorrow.

About Nutrition & Care

The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €3.61 billion in 2023 with more than 5,600 employees.

Disclaimer

In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

Media Contact:

Dr. Jürgen Krauter
Head of Market Communications
Tel +49 6181 59-6847
juergen.krauter@evonik.com

SOURCE: Evonik

MORE ON EVONIK, ETC.:

Follow EuropaWire on Google News
EDITOR'S PICK:

Comments are closed.